Advertisement
Australia markets close in 1 hour 14 minutes
  • ALL ORDS

    7,848.50
    -89.00 (-1.12%)
     
  • ASX 200

    7,587.20
    -95.80 (-1.25%)
     
  • AUD/USD

    0.6529
    +0.0006 (+0.09%)
     
  • OIL

    83.85
    +0.28 (+0.34%)
     
  • GOLD

    2,347.90
    +5.40 (+0.23%)
     
  • Bitcoin AUD

    98,367.73
    -152.56 (-0.15%)
     
  • CMC Crypto 200

    1,387.67
    +5.10 (+0.37%)
     
  • AUD/EUR

    0.6087
    +0.0014 (+0.23%)
     
  • AUD/NZD

    1.0959
    +0.0001 (+0.01%)
     
  • NZX 50

    11,813.52
    -132.91 (-1.11%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,626.75
    +342.21 (+1.98%)
     
  • NIKKEI 225

    38,017.57
    +389.09 (+1.03%)
     

Progyny, Inc. to Present at the BofA Global Healthcare Conference

NEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the BofA Global Healthcare Conference on Wednesday, September 15, 2021 at 10:55 A.M. Eastern Time, or 3:55 P.M. British Summer Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

ADVERTISEMENT

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com